Lv0
0 积分 2024-06-27 加入
Engineering therapeutic bispecific antibodies using CrossMab technology
1小时前
待确认
Engineering therapeutic bispecific antibodies using CrossMab technology
1小时前
已完结
Dose Selection for DuoBody®‐CD40x4‐1BB (GEN1042/BNT312) Using a mPBPK/RO Model Leveraging Preclinical and Clinical Data
28天前
已完结
Cysteine-SILAC Mass Spectrometry Enabling the Identification and Quantitation of Scrambled Interchain Disulfide Bonds: Preservation of Native Heavy-Light Chain Pairing in Bispecific IgGs Generated by Controlled Fab-arm Exchange
28天前
已完结
Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange
29天前
已完结
Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange
10个月前
已完结
Molecular engineering strategies and methods for the expression and purification of IgG1-based bispecific bivalent antibodies
1年前
已完结
Evaluation of strategies to control Fab light chain dimer during mammalian expression and purification: A universal one‐step process for purification of correctly assembled Fab
1年前
已完结
Mouse IgG2b monoclonal antibody fragmentation
1年前
已完结
Isolation and purification of recombinant proteins, antibodies and plasmid DNA with hydroxyapatite chromatography
1年前
已完结
皖公网安备34019202002308
